Madam President, what is the order? The PRESIDING OFFICER. We are in a period of morning business with Senators allowed to speak for up to 10 minutes each.

Mr. President, I ask unanimous consent that the Committee on Finance be authorized to meet during the session of the Senate on September 18, 2014. The PRESIDING OFFICER. Without objection, it is so ordered. COMMITTEE ON FOREIGN RELATIONS

Thank you so much, Madam President. I am here because I want to respond to the colloquy that was held on the Keystone Pipeline, but before I go there, I do want to make remarks about the very important vote we are going to be taking today…

Mr. Speaker, today we consider H.R. 2, ``the American Energy Solutions for Lower Costs and More American Jobs Act.'' I thank the gentleman from Nebraska, Mr. Terry, for his initiative on this bill. Title III of this bill includes H.R…

Madam President, I don't think we should adjourn and go home with matters of war and peace in front of us. This Senator certainly intends to support the appropriations bill, the continuing resolution necessary to keep the government…

Mr. President, today, I wish to bring awareness to the growing problem of falls amongst our seniors, the fastest-growing population in the United States. Each year, one out of every three older Americans over age 65 falls, resulting in…

Mr. President, today I announce my support of the Social Security Garnishment Modernization Act. I once again want to thank and commend Senator Collins, my co-sponsor on this legislation and co- leader on the Senate Special Committee on…

Mr. Chairman, we all understand that antibiotic resistant pathogens are a growing concern not only across the country, but across the globe.

However, despite these advances, there is still more work that needs to be done.

A combination of barriers, including, of course, the high cost of drug development and the small profit margins have helped to drive companies out of the anti-infectious space.

I am glad that Congress has been a true leader in this arena.

Fighting antibiotic resistance is both a public health and a national security priority.

If, before we left today and had a final vote on the CR, the majority leader would let a vote come to the floor to get 60 votes to go ahead and move forward on the Keystone Pipeline, in my belief it would happen. For all the reasons I…

I am pleased to join with the distinguished Senator from the State of North Dakota, and I am pleased to join with the Senator of Oklahoma. I am pleased to speak as an American from a State that is a net consumer, not producer, of energy…

Then I think, knowing the quality and the intellect of the 100 Members of the Senate, there is no doubt that if the leader would bring that vote to the floor today, we would get more than 60 votes to move America forward and say: This…

I want to commend you and the FDA on the efforts on the GAIN Act.

And I hope with this hearing today and we will be able to move the ADAPT Act across the line in the future.

Antibiotic resistance and development must be a high priority for this committee and central to the way we treat and cure disease in the 21st century.